Table 4.

The prevalence of the use (%) of medications for urological conditions by the presence of comorbidity among 5503 men and women in the BACH Survey

	Men using				Women using
Factor	UI/OAB druga	PBlS drugb	LUTS/BPH drugc	ED drugd	UI/OAB druga	PBlS drugb
Diabetes
Yes	0.57	2.09	7.38	8.01	3.43	3.11
No	0.53	0.66	3.13	2.06	1.52	1.50
P	0.942	0.178	0.025	0.107	0.122	0.114
Heart disease
Yes	0.28	1.26	7.70	7.65	4.19	1.93
No	0.56	0.74	3.05	2.04	1.49	1.63
P	0.318	0.506	0.011	0.026	0.130	0.741
Depressive symptoms
Yes	1.05	1.86	4.22	3.18	1.96	2.97
No	0.45	0.62	3.41	2.52	1.63	1.32
P	0.370	0.166	0.572	0.767	0.627	0.042
High blood pressure
Yes	0.93	1.34	6.57	5.65	2.69	3.65
No	0.39	0.60	2.45	1.54	1.31	0.86
P	0.312	0.192	< 0.001	0.014	0.053	0.002

P values from overall chi-square test. Medications were:

^aoxybutynin, tolterodine tartrate, propantheline bromide, hyoscyamine sulphate, and flavoxate hydrochloride

^bpentosan polysulphate and amitriptyline

^calfuzosin, doxazosin, tamsulosin, terazosin, and finasteride (no participant took dutasteride)

^dsildenafil, tadalafil, alprostadil, vardenafil, papaverine.